Sachinkumar B. Singh

644 total citations · 1 hit paper
26 papers, 410 citations indexed

About

Sachinkumar B. Singh is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Sachinkumar B. Singh has authored 26 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 4 papers in Epidemiology. Recurrent topics in Sachinkumar B. Singh's work include Cystic Fibrosis Research Advances (17 papers), Asthma and respiratory diseases (7 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Sachinkumar B. Singh is often cited by papers focused on Cystic Fibrosis Research Advances (17 papers), Asthma and respiratory diseases (7 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Sachinkumar B. Singh collaborates with scholars based in United States. Sachinkumar B. Singh's co-authors include Anthony J. Fischer, Timothy D. Starner, David A. Stoltz, Dominique H. Limoli, Tahuanty Peña, Steven M. Rowe, Anh T. Vo, Jill M. Van Dalfsen, Sarah J. Morgan and M. Skalland and has published in prestigious journals such as Journal of Clinical Investigation, American Journal of Respiratory and Critical Care Medicine and Cellular Microbiology.

In The Last Decade

Sachinkumar B. Singh

24 papers receiving 408 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist

2023 106 citations David P. Nichols, Sarah J. Morgan et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sachinkumar B. Singh United States	12	284	97	50	45	26	26	410
J.L. Whitehouse United Kingdom	13	298 1.0×	193 2.0×	62 1.2×	50 1.1×	100 3.8×	39	498
W.G. Flight United Kingdom	12	290 1.0×	64 0.7×	48 1.0×	175 3.9×	10 0.4×	35	428
Isabelle de Monestrol Sweden	8	220 0.8×	23 0.2×	32 0.6×	40 0.9×	19 0.7×	17	263
Tim Lee United Kingdom	6	595 2.1×	149 1.5×	48 1.0×	140 3.1×	73 2.8×	7	683
Nicole Mayer‐Hamblett United States	8	313 1.1×	80 0.8×	17 0.3×	89 2.0×	61 2.3×	16	366
A Equi United Kingdom	6	421 1.5×	92 0.9×	41 0.8×	176 3.9×	56 2.2×	7	541
Simon C Langton Hewer United Kingdom	10	389 1.4×	122 1.3×	13 0.3×	101 2.2×	82 3.2×	23	531
A. De Alessandri Italy	10	216 0.8×	85 0.9×	37 0.7×	36 0.8×	8 0.3×	21	395
E. Kerem Israel	8	408 1.4×	59 0.6×	28 0.6×	123 2.7×	41 1.6×	11	491
Anita Laxova United States	5	660 2.3×	109 1.1×	11 0.2×	103 2.3×	60 2.3×	5	733

Countries citing papers authored by Sachinkumar B. Singh

Since Specialization

Citations

This map shows the geographic impact of Sachinkumar B. Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sachinkumar B. Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sachinkumar B. Singh more than expected).

Fields of papers citing papers by Sachinkumar B. Singh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sachinkumar B. Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sachinkumar B. Singh. The network helps show where Sachinkumar B. Singh may publish in the future.

Co-authorship network of co-authors of Sachinkumar B. Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Sachinkumar B. Singh. A scholar is included among the top collaborators of Sachinkumar B. Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sachinkumar B. Singh. Sachinkumar B. Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wallace, Stuart R., et al.. (2024). Optimization‐Based Stable Balancing Weights Versus Propensity Score Weighting for Samples With High Covariate Imbalance. Pharmacoepidemiology and Drug Safety. 33(7). e5864–e5864. 1 indexed citations

Kapnadak, Siddhartha G., Matthew C. Radey, M. Teresi, et al.. (2023). 57 Bronchoscopy sampling finds that intra-lung bacterial migration contributes to persistent Pseudomonas aeruginosa infection after elexacaftor-tezacaftor-ivacaftor. Journal of Cystic Fibrosis. 22. S31–S31.

Nichols, David P., Sarah J. Morgan, M. Skalland, et al.. (2023). Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist. Journal of Clinical Investigation. 133(10). 106 indexed citations breakdown →

Teresi, M., et al.. (2023). Patient and Caregiver Perceptions of Airway Clearance Methods Used for Cystic Fibrosis. Canadian Respiratory Journal. 2023. 1–9. 1 indexed citations

Singh, Sachinkumar B., et al.. (2023). 95 The Role of Gender in Cognitive Outcomes from Stroke. Journal of the International Neuropsychological Society. 29(s1). 195–195. 1 indexed citations

Hornick, Douglas B., et al.. (2023). Impact of elexacaftor/tezacaftor/ivacaftor on bacterial cultures from people with cystic fibrosis. Pediatric Pulmonology. 58(5). 1569–1573. 18 indexed citations

Singh, Sachinkumar B., et al.. (2023). The role of gender in cognitive outcomes from stroke. Journal of the International Neuropsychological Society. 29(9). 878–884. 1 indexed citations

Chan, Christine L., Andrea Granados, Amir Moheet, et al.. (2022). Glycemia and β-cell function before and after elexacaftor/tezacaftor/ivacaftor in youth and adults with cystic fibrosis. Journal of Clinical & Translational Endocrinology. 30. 100311–100311. 14 indexed citations

Singh, Sachinkumar B. & Andreas Fischer. (2021). 23: CFTR modulators and new bacterial acquisition: A registry-based analysis using data from the CFFPR. Journal of Cystic Fibrosis. 20. S12–S12. 2 indexed citations

10.

Singh, Sachinkumar B., et al.. (2021). Impact of elexacaftor/tezacaftor/ivacaftor on vitamin D absorption in cystic fibrosis patients. Pediatric Pulmonology. 57(3). 655–657. 19 indexed citations

11.

Fischer, Anthony J., et al.. (2020). Sustained Coinfections with Staphylococcus aureus and Pseudomonas aeruginosa in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 203(3). 328–338. 61 indexed citations

12.

Allan, Richard, et al.. (2019). A Dose-Response Study Examining the Use of Methacholine Challenge to Demonstrate Local Therapeutic Equivalence of the Salmeterol Component of Generic Inhaled Fluticasone Propionate/Salmeterol Combination Products. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 32(6). 352–363. 1 indexed citations

13.

Singh, Sachinkumar B., Douglas B. Hornick, Janice L. Launspach, et al.. (2019). Randomized controlled study of aerosolized hypertonic xylitol versus hypertonic saline in hospitalized patients with pulmonary exacerbation of cystic fibrosis. Journal of Cystic Fibrosis. 19(1). 108–113. 11 indexed citations

14.

Singh, Sachinkumar B., et al.. (2019). Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftor. Pediatric Pulmonology. 54(8). 1200–1208. 31 indexed citations

15.

Singh, Sachinkumar B., et al.. (2019). Impact of pharmacy services on cystic fibrosis transmembrane conductance regulator modulator prescribing at a pediatric cystic fibrosis center. Pediatric Pulmonology. 54(10). 1591–1595. 13 indexed citations

16.

Singh, Sachinkumar B., et al.. (2018). Impact of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator on high‐dose ibuprofen therapy in pediatric cystic fibrosis patients. Pediatric Pulmonology. 53(8). 1035–1039. 6 indexed citations

17.

Singh, Sachinkumar B., et al.. (2016). Implementation of cystic fibrosis clinical pathways improved physician adherence to care guidelines. Pediatric Pulmonology. 52(2). 175–181. 8 indexed citations

18.

Mondal, Pritish, Mutasim Abu‐Hasan, Yaohui Zeng, et al.. (2015). Bioassay of salmeterol in children using methacholine challenge with impulse oscillometry. Pediatric Pulmonology. 51(6). 570–575. 2 indexed citations

19.

Singh, Sachinkumar B., Miles Weinberger, M. Bridget Zimmerman, & Timothy D. Starner. (2013). Growth of preschool age children receiving daily inhaled corticosteroids. Allergy and Asthma Proceedings. 34(6). 511–518. 3 indexed citations

20.

Lee, Andrew G., Rosa A. Tang, Gina Wong, Jade S. Schiffman, & Sachinkumar B. Singh. (2001). Isolated Inferior Rectus Muscle Palsy Resulting From a Nuclear Third Nerve Lesion as the Initial Manifestation of Multiple Sclerosis. Journal of Neuro-Ophthalmology. 20(4). 246–247. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact